Post by
Duster340 on Apr 25, 2024 9:01am
Outlook for 2024
i am thinking once tilray gets things turned around they also could be the company that buys out ndva mr simon likes to make aquisitions marijuanna, kraft beer why not edibles ndva already does business with them. ( Indiva began supplying Tilray Brands, Inc.'s ("Tilray") medical platform with Indiva products. Products are now available to Tilray medical patients including Pearls by Grn, Wana Sour Gummies, Bhang Chocolate as well as Doppio Sandwich Cookies.)
For the fiscal year 2024, the Company expects to generate record net revenue and record EBITDA, driven by continued strength in its core brands, bolstered by new product introductions and continued efficiency gains at the production facility from automation and process improvements.
Comment by
caretired1 on Apr 25, 2024 9:16am
Yah and with Health Cda not meddling like they did with lozenges, Gron and No Future selling for a full year
Comment by
caretired1 on Apr 27, 2024 8:53am
If I was Canopy, I would buy Indiva, especially now that the CGC stock has some currency again. They would keep all the Wana margin in Canada and make expansion into Michigan, Ohio, New York easier with the great team in London providing all of the intellect and operations expertise.
Comment by
Duster340 on Apr 30, 2024 2:17pm
Or tilray when legalized in the us tilray is already set-up for business. i think our value as a takeover candidate has gone up with the DEA anounncment today, safe banking next, then legalization. multiple buyers? flush with cash.